Oct 25, 2022 / 12:00PM GMT
Presentation
Oct 25, 2022 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Harry Kirsch
Novartis AG - CFO
* Samir Shah
Novartis AG - Global Head of IR
* Vasant Narasimhan
Novartis AG - CEO
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emily Field
Barclays Bank PLC, Research Division - Research Analyst
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Florent Cespedes
Societe Generale Cross Asset Research - Senior Equity Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Kerry Ann Holford
Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Mark Douglas Purcell
Novartis AG
(BSP:N1VS34)
R$
64.54
4.05 (6.7%)
Market Cap: 1.29 Tn
Enterprise Value: 1.39 Tn
PE Ratio: 13.36
PB Ratio: 5.41
GF Score: 77/100 Q3 2022 Novartis AG Earnings Presentation Transcript
Oct 25, 2022 / 12:00PM GMT
Release Date Price:
R$40.36
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot